FDA Person
Office of Regulatory AffairsAneel K. Sandhu
View detailed information about Aneel K. Sandhu, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of Regulatory Affairs. Took part in 3 inspections of 3 companies, 2018–2019.
Inspections (3)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| February 28, 2019 | Biocentric Lab LLC | OAI | Blood and Blood Products | #1080744 |
| August 2, 2018 | Synergy Health AST, LLC | NAI | Human Cellular, Tissue, and Gene Therapies | #1064088 |
| July 10, 2018 | American National Red Cross (The) | NAI | Blood and Blood Products | #1061522 |
Documents (8)
- 483 · Theranos, Inc. · August 18, 2016
- EIR · Roche Molecular Systems, Inc. · February 27, 2017
- EIR · Flavio Vincenti, M.D. · November 4, 2009
- 483 · BioMarin Pharmaceuticals, Inc. · September 24, 2013
- 483 · Stanford Blood Center · June 16, 2010
- EIR · Theranos, Inc. · August 16, 2016
- 483 · BioMarin Pharmaceuticals, Inc. · September 24, 2013
- EIR · Exelixis, Inc. · September 27, 2012
Frequently inspected with (4)
Related Office
Person Information
Name
Aneel K. Sandhu
Title
Government Employee
Role
Regulatory Personnel
ID: 426b5d36-5c58-4f2e-ae8c-7076f8f52029
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.